HMS Holdings Corp (NASDAQ:HMSY) has been assigned a consensus recommendation of “Buy” from the fourteen ratings firms that are presently covering the stock, Marketbeat.com reports. Four research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. The average 1 year price target among brokers that have covered the stock in the last year is $32.93.
Several brokerages have commented on HMSY. Zacks Investment Research upgraded shares of HMS from a “hold” rating to a “buy” rating and set a $32.00 target price for the company in a research report on Wednesday, January 16th. BidaskClub lowered shares of HMS from a “buy” rating to a “hold” rating in a research note on Wednesday, January 16th. Finally, Cantor Fitzgerald reaffirmed a “hold” rating and issued a $34.00 target price on shares of HMS in a research note on Friday, February 22nd.
HMSY stock traded up $0.63 during trading on Monday, hitting $32.01. The company had a trading volume of 1,764 shares, compared to its average volume of 623,767. The company has a debt-to-equity ratio of 0.34, a current ratio of 5.34 and a quick ratio of 4.40. HMS has a 12 month low of $20.73 and a 12 month high of $38.15. The stock has a market capitalization of $2.66 billion, a PE ratio of 37.89, a price-to-earnings-growth ratio of 2.69 and a beta of 1.59.
In other news, insider Teresa South sold 216,903 shares of the stock in a transaction dated Thursday, February 28th. The shares were sold at an average price of $34.57, for a total transaction of $7,498,336.71. Following the completion of the transaction, the insider now directly owns 137,622 shares in the company, valued at approximately $4,757,592.54. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, insider Meredith W. Bjorck sold 2,362 shares of the stock in a transaction dated Monday, April 15th. The stock was sold at an average price of $30.10, for a total transaction of $71,096.20. Following the transaction, the insider now owns 51,755 shares of the company’s stock, valued at $1,557,825.50. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 1,018,795 shares of company stock valued at $35,023,853. Company insiders own 2.87% of the company’s stock.
Several institutional investors have recently bought and sold shares of HMSY. Parallel Advisors LLC bought a new position in HMS in the 1st quarter valued at about $25,000. Financial Gravity Wealth Inc. bought a new position in shares of HMS during the first quarter worth approximately $46,000. Premia Global Advisors LLC bought a new position in shares of HMS during the first quarter worth approximately $47,000. Quadrant Capital Group LLC increased its holdings in shares of HMS by 97.4% during the first quarter. Quadrant Capital Group LLC now owns 1,601 shares of the business services provider’s stock worth $46,000 after purchasing an additional 790 shares during the period. Finally, We Are One Seven LLC bought a new position in shares of HMS during the fourth quarter worth approximately $84,000. Institutional investors own 93.37% of the company’s stock.
HMS Holdings Corp., through its subsidiaries, provides cost containment solutions in the United States healthcare marketplace. The company offers coordination of benefits services to government and commercial healthcare payers to ensure that the correct party pays the claim; and population management solutions that provide risk-bearing organizations with intelligence across their member populations to identify risks, and enhance patient engagement and outcomes, as well as payment integrity, care management and consumer engagement, and analytical solutions.
Further Reading: Quick Ratio
Receive News & Ratings for HMS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HMS and related companies with MarketBeat.com's FREE daily email newsletter.